Contact Us
繁
簡
EN
ABOUT ONENESS
Company Info
Company Organization
History
Core Value & Business Philosophy
Team
Global Partnership
Nanchou Plant
CEO Conversation
Animal Center
SCIENCE
PIPELINE
R & D
ON101
FB825
FB704A
SNS812
SNS851
Research Publication/ Abstract
FESPIXON®
FESPIXON® Cream
About Diabetic Foot Ulcers
Expanded Access Program
Medical Subsidies for low-Income DFU Patients
Care for Diabetic Foot
The Ph3 Data and the Mechanism of Action of FESPIXON®(ON101)
FESPIXON® received International Innovation Awards from Enterprise Asia
Bonvadis®
Hospital Location
Health Education
Diabetic Foot Care
ESG
ESG Overview
Message from the Chairman
Sustainable Management Structure
Stakeholders Engagement and Material Topics
2025 Sustainability Goals
Response to SDGs
ESG Awards and Highlights
Corporate Governance
Legal Compliance
Product Safety
Supply Chain Management
Environmental Protection
Environmental Management Systems
Climate Actions
Water Resources
Biodiversity
Chemical Substances and Waste Management
Social Inclusion
Diverse and Equal Workplace
Labor Rights
Talent Attraction, Retention, and Development
Healthy and Safe Working Environment
Access to Medicine
Social Engagement
ESG InfoHub
Latest ESG Report
Past ESG Reports
ESG Verification
Video Station
INVESTORS
Governance
Board of Directors
Functional Committee
Corporate Governance Officer Appointment
Internal Audit
Ethical Corporate Management
Risk Management
Cyber Security Management
Intellectual Property Management
Major Internal Policies
Shareholder Service
Annual Report
Shareholding Structure
Shareholder’s Meeting
Stock Quotes
Stock Dividend
Events & Presentations
Contact Audit Committee
Financial
Financial Report
Monthly Revenue
Investor FAQs
Investor Relations Contacts
NEWS
2025
2024
2023
2022
2021
2020
2019
2018
2017
CAREER
Choose Oneness Biotech
Learning Development
Compensation & Benefits
Join Us
Contact Us
繁
簡
EN
ABOUT ONENESS
Company Info
Company Organization
History
Core Value & Business Philosophy
Team
Global Partnership
Nanchou Plant
CEO Conversation
Animal Center
SCIENCE
PIPELINE
R & D
ON101
FB825
FB704A
SNS812
SNS851
Research Publication/ Abstract
FESPIXON®
FESPIXON® Cream
About Diabetic Foot Ulcers
Expanded Access Program
Medical Subsidies for low-Income DFU Patients
Care for Diabetic Foot
The Ph3 Data and the Mechanism of Action of FESPIXON®(ON101)
FESPIXON® received International Innovation Awards from Enterprise Asia
Bonvadis®
Hospital Location
Health Education
Diabetic Foot Care
ESG
ESG Overview
Message from the Chairman
Sustainable Management Structure
Stakeholders Engagement and Material Topics
2025 Sustainability Goals
Response to SDGs
ESG Awards and Highlights
Corporate Governance
Legal Compliance
Product Safety
Supply Chain Management
Environmental Protection
Environmental Management Systems
Climate Actions
Water Resources
Biodiversity
Chemical Substances and Waste Management
Social Inclusion
Diverse and Equal Workplace
Labor Rights
Talent Attraction, Retention, and Development
Healthy and Safe Working Environment
Access to Medicine
Social Engagement
ESG InfoHub
Latest ESG Report
Past ESG Reports
ESG Verification
Video Station
INVESTORS
Governance
Board of Directors
Functional Committee
Corporate Governance Officer Appointment
Internal Audit
Ethical Corporate Management
Risk Management
Cyber Security Management
Intellectual Property Management
Major Internal Policies
Shareholder Service
Annual Report
Shareholding Structure
Shareholder’s Meeting
Stock Quotes
Stock Dividend
Events & Presentations
Contact Audit Committee
Financial
Financial Report
Monthly Revenue
Investor FAQs
Investor Relations Contacts
NEWS
2025
2024
2023
2022
2021
2020
2019
2018
2017
CAREER
Choose Oneness Biotech
Learning Development
Compensation & Benefits
Join Us
Category
2020
22
Jun
2020 2nd (June) Investor Conference
2020 年 6 月 22 日
jane
2020
,
investor
Date 2020/06/22 Location Online Presentation Download Download Chinese Version Download English Version Note N/A
Read More
26
May
Oneness Biotech will proceed to unblind Phase 3 data of ON101 MRCT (protocol#ON101CLCT02) according to TFDA notification letter# 1096013906
2020 年 5 月 26 日
bryant6831
2020
,
Latest News
Published Date:2020-05-26 Original Link:https://www.onenessbio.com/en/news_detail108_1.htm Contact Us繁簡EN
Read More
14
May
Oneness Biotech receives upfront payment of US$14.48M from LEO Pharma A/S
2020 年 5 月 14 日
bryant6831
2020
,
Latest News
Published Date:2020-05-14 Original Link:https://www.onenessbio.com/en/news_detail109_1.htm Contact Us繁簡EN
Read More
15
Apr
Press Conference of LEO Pharma Enters License Agreement with Oneness Biotech
2020 年 4 月 15 日
jane
2020
,
investor
Date 2020/04/15 Location Online Presentation Download Download Chinese Version Download English Version Note N/A
Read More
24
Mar
2020 1st (March) Investor Conference
2020 年 3 月 24 日
jane
2020
,
investor
Date 2020/03/24 Location Online Presentation Download Download Chinese Version Download English Version Note N/A
Read More
25
Feb
Oneness Biotech receives an upfront payment of US$4M from a global pharma company.
2020 年 2 月 25 日
bryant6831
2020
,
Latest News
Published Date:2020-02-25 Original Link:https://www.onenessbio.com/en/news_detail80_1.htm Contact Us繁簡EN
Read More
11
Feb
Oneness Biotech, jointly with affiliate company, Microbio (Shanghai), signs a collaboration memorandum with global pharma company.
2020 年 2 月 11 日
bryant6831
2020
,
Latest News
Published Date:2020-02-11 Original Link:https://www.onenessbio.com/en/news_detail78_1.htm Contact Us繁簡EN
Read More
12
Jan
38th Annual J.P. Morgan Healthcare Conference
2020 年 1 月 12 日
jane
2020
,
investor
Date 2020/01/12 Location Westin St. Francis Hote Presentation Download Download Chinese Version Download English Version Note N/A
Read More
03
Jan
Oneness Biotech has been invited for oral presentation at the 38th Healthcare Conference organized by J.P. Morgan
2020 年 1 月 3 日
bryant6831
2020
,
Latest News
Published Date:2020-01-03 Original Link:https://www.onenessbio.com/en/news_detail76_1.htm Contact Us繁簡EN
Read More
1
2